Correlation between urinary activity of N-acetyl-β-d-glucosaminidase (NAG) and albumin excretion rate in type II (non-insulin-dependent) diabetic subjects

1987 ◽  
Vol 24 (2) ◽  
pp. 149-155 ◽  
Author(s):  
Giuseppa Perdichizzi ◽  
Domenico Cucinotta ◽  
Rosalba Fera ◽  
Enrico Cesare ◽  
Salvatore Campo ◽  
...  
Keyword(s):  
Excretion Rate ◽  
Albumin Excretion Rate ◽  
Type Ii ◽  
Albumin Excretion ◽  
Insulin Dependent ◽  
Insulin Dependent Diabetic

Glycosaminoglycans as a Possible Tool for Micro- and Macroalbuminuria in Diabetic Patients. A Pilot Study

1997 ◽  
Vol 25 (2) ◽  
pp. 81-86 ◽  
Author(s):  
G Sorrenti ◽  
M Grimaldi ◽  
N Canova ◽  
E Palazzini ◽  
N melchionda
Keyword(s):  
Type Ii Diabetes ◽  
Excretion Rate ◽  
Albumin Excretion Rate ◽  
Favourable Effect ◽  
Diabetic Patients ◽  
Type Ii ◽  
Therapeutic Tool ◽  
Albumin Excretion ◽  
End Of Treatment

The aim was to investigate sulodexide as a possible therapeutic tool for treating micro- and macroalbuminuria in diabetic patients. Fifteen patients (13 micro- and 2 macroalbuminuric) with Type II diabetes, were treated with 600 lipoprotein-lipase releasing units of sulodexide by the intramuscular route, daily for 28 days, and followed up for 2 months. The main evaluation parameter was the albumin excretion rate. At the end of treatment, six of the 13 microalbuminuric patients showed a decrease in the albumin excretion rate, which increased again in three of the six during follow-up. In the two macroalbuminuric patients the albumin excretion rate decreased at the end of treatment and remained unchanged after a further 2 months. Overall analysis (15 patients) showed a significant decrease ( P < 0.05) in the albumin excretion rate compared with baseline. Metabolic control and blood pressure remained unchanged during the entire period of study. No adverse events were registered. It is concluded that sulodexide administration has a favourable effect in reducing the albumin excretion rate in Type II diabetic patients with micro- and macroalbuminuria.

Proteomic analysis for the assessment of diabetic renal damage in humans

2004 ◽  
Vol 107 (5) ◽  
pp. 485-495 ◽  
Author(s):  
Harald MISCHAK ◽  
Thorsten KAISER ◽  
Michael WALDEN ◽  
Meike HILLMANN ◽  
Stefan WITTKE ◽  
...  
Keyword(s):  
Proteomic Analysis ◽  
Type Ii Diabetes ◽  
Renal Damage ◽  
Excretion Rate ◽  
Albumin Excretion Rate ◽  
Low Grade ◽  
Type Ii ◽  
Polypeptide Pattern ◽  
Albumin Excretion ◽  
Normal Albumin

Renal disease in patients with Type II diabetes is the leading cause of terminal renal failure and a major healthcare problem. Hence early identification of patients prone to develop this complication is important. Diabetic renal damage should be reflected by a change in urinary polypeptide excretion at a very early stage. To analyse these changes, we used an online combination of CE/MS (capillary electrophoresis coupled with MS), allowing fast and accurate evaluation of up to 2000 polypeptides in urine. Employing this technology, we have examined urine samples from 39 healthy individuals and from 112 patients with Type II diabetes mellitus and different degrees of albumin excretion rate. We established a ‘normal’ polypeptide pattern in the urine of healthy subjects. In patients with Type II diabetes and normal albumin excretion rate, the polypeptide pattern in urine differed significantly from normal, indicating a specific ‘diabetic’ pattern of polypeptide excretion. In patients with higher grade albuminuria, we were able to detect a polypeptide pattern indicative of ‘diabetic renal damage’. We also found this pattern in 35% of those patients who had low-grade albuminuria and in 4% of patients with normal albumin excretion. Moreover, we could identify several of the indicative polypeptides using MS/MS sequencing. We conclude that proteomic analysis with CE/MS permits fast and accurate identification and differentiation of polypeptide patterns in urine. Longitudinal studies should explore the potential of this powerful diagnostic tool for early detection of diabetic renal damage.

SPECIFIC THROMBOXANE SYNTHETASE INHIBITION AND ALBUMIN EXCRETION RATE IN INSULIN-DEPENDENT DIABETES

The Lancet ◽  
1984 ◽  
Vol 323 (8390) ◽  
pp. 1322-1325 ◽  
Author(s):  
A.H. Barnett ◽  
B.A. Leatherdale ◽  
A. Polak ◽  
M. Toop ◽  
K. Wakelin ◽  
...  
Keyword(s):  
Excretion Rate ◽  
Albumin Excretion Rate ◽  
Insulin Dependent Diabetes ◽  
Albumin Excretion ◽  
Thromboxane Synthetase ◽  
Insulin Dependent

scholarly journals Heritability of albumin excretion rate in families of patients with Type II diabetes

Diabetologia ◽  
1999 ◽  
Vol 42 (11) ◽  
pp. 1359-1366 ◽  
Author(s):  
C. M. Forsblom ◽  
T. Kanninen ◽  
M. Lehtovirta ◽  
C. Saloranta ◽  
L. C. Groop
Keyword(s):  
Type Ii Diabetes ◽  
Excretion Rate ◽  
Albumin Excretion Rate ◽  
Type Ii ◽  
Albumin Excretion

Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate

1995 ◽  
Vol 9 (4) ◽  
pp. 272-276 ◽  
Author(s):  
Sianna Panagiotopoulos ◽  
Trudy Jeanne Smith ◽  
G.Peter Aldred ◽  
Elizabeth Jane Baker ◽  
Carolyn Jane Jacklin ◽  
...  
Keyword(s):  
Gene Polymorphism ◽  
Angiotensin Converting Enzyme ◽  
Excretion Rate ◽  
Albumin Excretion Rate ◽  
Diabetic Patients ◽  
Type Ii ◽  
Converting Enzyme ◽  
Albumin Excretion ◽  
Ace Gene ◽  
Ace Gene Polymorphism
Sign in / Sign up

Export Citation Format

Share Document